Skin cancer: An overview of epidemiology and risk factors

Seminars in Oncology Nursing

Volumn 29, Issue 3, 2013, Pages 160-169

  Gordon, Randy ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Melanoma; Non melanoma skin cancer; Skin cancer; Skin cancer clinical presentation; Skin cancer epidemiology; Skin cancer risk factors

Indexed keywords

ARTICLE; CLASSIFICATION; HISTOLOGY; HUMAN; MELANOMA; NON-MELANOMA SKIN CANCER; PATHOPHYSIOLOGY; RISK FACTOR; SKIN; SKIN CANCER; SKIN CANCER CLINICAL PRESENTATION; SKIN CANCER EPIDEMIOLOGY; SKIN CANCER RISK FACTORS; SKIN TUMOR;

MELANOMA; NON-MELANOMA SKIN CANCER; SKIN CANCER; SKIN CANCER CLINICAL PRESENTATION; SKIN CANCER EPIDEMIOLOGY; SKIN CANCER RISK FACTORS;

HUMANS; RISK FACTORS; SKIN; SKIN NEOPLASMS;

EID: 84882247721     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2013.06.002     Document Type: Article

References (45)

1. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012, 166:1069-1080.
2. Flohil S.C., de Vries E., Neumann M., et al. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011, 91:24-30.
3. World Health Organization (WHO). Skin cancers. Available at: Accessed November 23,2012. http://www.who.int/uv/faq/skincancer/en/print.html.
4. American Cancer Society. Cancer Facts & Figures 2012.Available at: Accessed November 18,2012. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf.
5. Erdmann F., Lortet-Tieulent J., Schuz J., et al. International trends in the incidence of malignant melanoma 1953-2008-arerecent generations at higher or lower risk?. Int J Cancer 2013, 132:385-400.
6. Narayanan D.L., Saladi R.N., Fox J.L. Ultraviolet radiation and skin cancer. Int J Dermatol 2010, 49:978-986.
7. Maden V., Leah J.T., Szeimies R.M. Non-melanoma skin cancer. Lancet 2010, 375:673-685.
8. National Cancer Institute. Anatomy of the skin. Available at: Accessed February, 8,2013. http://https://commons.wikimedia.org/wiki/File:Layers_of_the_skin.jpg.
9. Watkins J. Skin rashes, part 1: skin structure and taking a dermatological history. Pract Nurs 2013, 24:30-33.
10. Brenner M., Hearing V.L. The protective role of melanin against UV damage in human skin. Photochem Photobiol 2007, 84:539-549.
11. Benjamin C.L., Ananthaswamy H.N. p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 2007, 224:241-248.
12. Chang N.B., Feng R., Gao Z., et al. Skin cancer incidence is highly associated with ultraviolet-B radiation history. Int J Hyg Environ Health 2010, 213:359-368.
13. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysisofrisk factors for cutaneous melanoma: II sun exposure. Eur J Cancer 2005, 41:45-60. 10.1016/j.ejca.2004.10.016.
14. Marshall S.E., Bordea C., Haldar N.A., et al. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int 2000, 58:2186-2193.
15. Feuerstein I., Geller A.C. Skin cancer education in transplant recipients. Transplantation 2008, 18:232-242.
16. Porter R.S. The Merck manual of diagnosis and therapy 2011, Merck Sharpe & Dohme Corp, West Point, PA. 19th ed.
17. McCormack C.J., Kelly J.W., Dorevitch A.P. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma: a possible indicator of differing causes. Arch Dermatol 1997, 133:593-596.
18. Firnhaber J.M. Diagnosis and treatment of basal cell and squamous cell carcinoma. Am Fam Physician 2012, 86:161-168.
19. Cummins D.L., Cummins J.M., Hardin P., et al. Cutaneous malignant melanoma. Mayo Clin Proc 2006, 81:500-507.
20. Fagundo E., Rodríguez-García C., Rodríguez C., et al. Analysis of phenotypic characteristics and exposure to UV radiation in a group of patients with cutaneous melanoma. Actas Dermosifiliogr 2011, 102:599-604.
21. Cainia S., Gandini S., Sera F., et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer 2009, 45:3054-3063.
22. Thompson J.F., Scolyer R.A., Kefford R.F. Cutaneous melanoma. Lancet 2005, 365:687-701.
23. Geller A.C., Colditz G., Oliveria S., et al. Use of sunscreen, sunburning rates, and tanning bed use among more than 10,000 US children and adolescents. Pediatrics 2002, 109:1009-1014.
24. Karagas M.R., Zens M.S., Nelson H.H., et al. Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. Am J Epidemiol 2007, 165:719-726.
25. Kwasniak L.A., Garcia-Zuazaga J. Basal cell carcinoma: evidence-based medicine and review of treatment modalities. Int J Dermatol 2011, 50:645-658.
26. Davies A. The effective management of squamous cell carcinoma. Br J Nurs 2009, 18:539-543.
27. Tessari G., Girolomoni G. Nonmelanoma skin cancer insolid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg 2012, 38:1622-1630.
28. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988, 124:869-871.
29. Green A., Maclennan R., Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer 1985, 35:297-300.
30. Andersson K., Michael K.M., Luostarinen T., et al. Prospective study of human papillomavirus seropositivity and risk ofnonmelanoma skin cancer. Am J Epidemiol 2012, 175:685-695.
31. Ulrich C., Schmook T., Sachse M.M., et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004, 30:622-627.
32. Garg S., Carroll R.P., Walker R.G., et al. Skin cancer surveillance in renal transplant recipients: Re-evaluation of U.K. practice and comparison with Australian experience. Br J Dermatol 2009, 160:177-179.
33. Glover M.T., Deeks J.J., Raftety M.J., et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997, 349:398.
34. Micke O., Bruns F., Schafer U., et al. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy. Anticancer Res 2005, 25:1663-1665.
35. Ridky T.W. Nonmelanoma skin cancer. J Am Acad Dermatol 2007, 57:484-501.
36. Kiiski V., de Vries E., Flohil S.C., et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010, 146:848-855.
37. Czarnecki D., Sutton T., Czarnecki C., et al. A 10-year prospective study of patients with skin cancer. J Cutan Med Surg 2002, 6:427-429.
38. Marcil I., Stern R.S. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000, 136:1524-1530.
39. Pichon L.C., Corral I., Landrine H., et al. Perceived skin cancer risk and sunscreen use among African American adults. J Health Psychol 2010, 15:1181-1189.
40. Branstrom R., Kristjansson S. Ullen H. Health-related behaviours: Risk perception, optimistic bias, and readiness to change sun related behaviours. Eur J Public Health 2005, 16:492-497.
41. Schmidt C.W. UV radiation & skin cancer: the science behind age restrictions for tanning beds. Environ Health Perspect 2012, 120:308-313.
42. Neeman A., Lea C.S., Lesesky E.B. Reasons for tanning bed use: a survey of community college students in North Carolina. N C Med J 2012, 73:89-92.
43. Boniol M., Autier P., Boyle P., et al. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 2012, 345:e4757.
44. Buster K.J., You Z., Fouad M., et al. Skin cancer risk perceptions: a comparison across ethnicity, age, education, gender, and income. J Am Acad Dermatol 2012, 66:771-779.
45. Applebaum K.S., Karagas M.R., Hunter D.J. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Environ Health Perspect 2007, 115:1231-1236.